public access to the JAK inhibitor upadacitibin for patients with eczema, ulcerative colitis, Crohn's disease, and rheumatoid arthritis
Up to 12 framings across outlets and orientations — each a short phrase the extractor generated to characterise the piece's editorial angle (not a quote). Filter by lean to see how each bloc is spinning the story; click through to read the original.
expanded public funding for eczema treatments
Thousands to benefit as pharmac widens access to four medicinesStacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 1 articles linking to this topic.
Spotted something wrong on this page? Report a correction.